…
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Betashares Global Healthcare Currency Hedged ETF provides Australian investors with diversified equity exposure to large global healthcare companies while hedging currency exposure to the Australian dollar. Long-term drivers include ageing populations, rising global healthcare spending, and ongoing medical and biotech innovation. The ETF may appeal to investors seeking defensive sector exposure with reduced currency risk relative to unhedged global healthcare holdings.
Key risks include sector concentration and exposure to regulatory and clinical trial outcomes, along with potential hedging costs and equity market volatility that could impair returns.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| DRUG Betashares Global Healthcare Currency Hedged ETF |
0.07 0.71% |
9.97 | - | - | - | - |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.